Immunofluorescence Assay Market: High Growth Opportunities in Emerging Markets
The study involved four major activities in estimating the current size of the immunofluorescence assay
market. Exhaustive secondary research was done to collect information on the market and its different
subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts
across the value chain through primary research. Both top-down and bottom-up approaches were
employed to estimate the complete market size. After that, market breakdown and data triangulation
procedures were used to estimate the market size of the segments and subsegments.
Download a PDF Brochure @
Major Market Growth Drivers:
The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and
rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth
opportunities for players operating in the immunofluorescence assays market in the coming years.
However, quality concerns over antibodies are the major challenge in this market.
Revenue Growth Analysis:
[203 Pages Report] The global immunofluorescence assays market is projected to reach USD 3.5 billion
by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.
Browse and in-depth TOC on" Immunofluorescence Assay Market"
174 – Tables
39 – Figures
203 – Pages
Indirect immunofluorescence segment accounted for the highest CAGR
Based on type, the immunofluorescence assays market is segmented into indirect immunofluorescence
and direct immunofluorescence. In 2020, indirect immunofluorescence accounted for accounted for the
highest growth rate. The major factors driving the growth of this segment are its advantages such as
sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence.
Request a Sample Pages: